The multiomics global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Multiomics Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size – The multiomics market size has grown rapidly in recent years. It will grow from $2.78 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to Increased biomedical research, increased government and private funding, a rise in the prevalence of chronic diseases, technological advancements, and enhanced computational tools and software for data analysis.
The multiomics market size is expected to see rapid growth in the next few years. It will grow to $6.28 billion in 2028 at a compound annual growth rate (CAGR) of 17.8%. The growth in the forecast period can be attributed to advances in artificial intelligence and machine learning, expansion of clinical applications, growing biopharmaceutical industry, emergence of integrated multiomics platforms, and increasing use in agricultural and environmental research. Major trends in the forecast period include technological advancements, the launch of new commerical multiomics platforms, the adoption of spatially resolved multiomics analysis, adoption in biopharmaceutical research and development, and expansion into clinical diagnostics.
Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report
Scope Of Multiomics MarketThe Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Multiomics Market Overview
Market Drivers -The rising demand for personalized medicine is expected to propel the growth of the multiomics market going forward. Personalized medicine refers to a medical approach that customizes healthcare decisions and treatments to individual patients based on their genetic, environmental, and lifestyle factors. This personalized medicine approach is rising due to technological advancements, increasing demand for targeted therapies, and global healthcare improvements. Multiomics helps personalized medicine by providing a detailed understanding of an individual’s genetic, molecular, and metabolic profile, enabling healthcare providers to tailor treatments based on the specific characteristics of each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the multiomics market.
Market Trends – Major companies operating in the multiomics market are developing advanced single-cell multiomics platforms to enable scientists to run large-scale studies without sacrificing sample integrity. Single-cell multiomics platforms integrate various omics with artificial intelligence capabilities, allowing users to seamlessly analyze and interpret complex biological data through sophisticated algorithms and machine learning techniques. For instance, in February 2023, Becton, Dickinson, and Company, a US-based medical device company, launched the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This innovative system enables scientists to isolate, barcode, and analyze single cells at a high sample throughput, accommodating up to eight times more cells than previous versions of BD single-cell analyzers. The BD Rhapsody HT Xpress System ensures no sample loss, offering flexibility to analyze multiple samples and different cell sizes and types simultaneously, such as stem cells or cancer cells, enhancing researchers’ ability to gain more insights in less time.
The multiomics market covered in this report is segmented –
1) By Type: Single-Cell Multiomics, Bulk Multiomics
2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms
3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications
4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users
Get an inside scoop of the multiomics market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp
Regional Insights – North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies – Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group
Table of Contents 1. Executive Summary2. Multiomics Market Report Structure3. Multiomics Market Trends And Strategies4. Multiomics Market – Macro Economic Scenario5. Multiomics Market Size And Growth…..27. Multiomics Market Competitor Landscape And Company Profiles28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
